Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

INHX

Inhibitex, Inc. (MM) (INHX)

Inhibitex, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:INHX
FechaHoraFuenteTítuloSímboloCompañía
13/02/201210:55Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:INHXInhibitex, Inc. (MM)
13/02/201207:22Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:INHXInhibitex, Inc. (MM)
13/02/201205:03Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:INHXInhibitex, Inc. (MM)
09/02/201212:13Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:INHXInhibitex, Inc. (MM)
07/02/201208:00MarketwiredA Forward Look, the Year Ahead - Featured Research on Inhibitex, Inc. and Idenix Pharmaceuticals, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
06/02/201207:18Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:INHXInhibitex, Inc. (MM)
03/02/201214:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INHXInhibitex, Inc. (MM)
26/01/201211:32Dow Jones NewsUPDATE: Bristol-Myers 4Q Net Up 76% On Lower Taxes But Results Miss ViewsNASDAQ:INHXInhibitex, Inc. (MM)
26/01/201208:11Dow Jones NewsBristol-Myers 4Q Net Up 76% On Lower Taxes But Results Miss ViewsNASDAQ:INHXInhibitex, Inc. (MM)
26/01/201207:56ZacksBristol-Myers Misses on All Fronts - Analyst BlogNASDAQ:INHXInhibitex, Inc. (MM)
23/01/201203:00ZacksEarnings Preview: Bristol-Myers - Analyst BlogNASDAQ:INHXInhibitex, Inc. (MM)
20/01/201202:30ZacksThe Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals & Merck - Press R..NASDAQ:INHXInhibitex, Inc. (MM)
19/01/201207:15ZacksGilead Clinches Pharmasset Buy - Analyst BlogNASDAQ:INHXInhibitex, Inc. (MM)
17/01/201215:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INHXInhibitex, Inc. (MM)
17/01/201205:15Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:INHXInhibitex, Inc. (MM)
13/01/201215:59Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:INHXInhibitex, Inc. (MM)
13/01/201215:21Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:INHXInhibitex, Inc. (MM)
13/01/201213:07MarketwiredThe Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Inhibitex, I...NASDAQ:INHXInhibitex, Inc. (MM)
11/01/201210:50PR Newswire (US)Potentially Unfair Tender Offer for Inhibitex Triggers Shareholder-Claim Investigation by Securities Class Action Lawyers at ...NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201219:28Dow Jones NewsMerck Will Consider Deals To Expand Hepatitis C Drug LineupNASDAQ:INHXInhibitex, Inc. (MM)
10/01/201218:06Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibi...NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201218:00Business WireFaruqi & Faruqi, LLP Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201215:17Edgar (US Regulatory)Current report filing (8-K)NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201214:57Business WireLaw Firm Brower Piven Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201209:37Business WireRyan & Maniskas, LLP Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201205:04Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:INHXInhibitex, Inc. (MM)
10/01/201202:30ZacksThe Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset - Press ReleasesNASDAQ:INHXInhibitex, Inc. (MM)
09/01/201218:03Business WireLaw Offices of Howard G. Smith Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
09/01/201215:02Business WirePomerantz Law Firm Investigates Claims on Behalf of Investors of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
09/01/201212:10Business WireHarwood Feffer LLP Announces Investigation of Inhibitex, Inc.NASDAQ:INHXInhibitex, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:INHX

Su Consulta Reciente